Analysis of heparinase derived LMWH products using a MHC 2D LC system linked to Q-TOF MS

Lei Chen,Wen Zhu,Na Yan,Yan Guo,Lin Yi,Yilan Ouyang,Zhenqing Zhang
DOI: https://doi.org/10.1016/j.jpba.2022.114616
IF: 3.571
2022-04-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:Low molecular weight heparins (LMWHs), depolymerized from unfractionated heparin (UFH), are widely used as anticoagulant drugs in clinic. The variable degradation methods result the different types of LMWHs, such as enoxaparin prepared by alkaline degradation following benzylation and nadroparin degraded by nitrous acid and subsequent reduction. They have different anticoagulant activities, molecular weight and special oligosaccharide sequences. Oligosaccharide analysis of the heparinase-catalyzed digestion products of heparin and LMWHs is an important way to explore the fine structural composition. In this work, a MHC-2D-LC-MS system using SAX followed by SEC and tandem to MS was applied to analyze the heparinase-products of LMWHs. 15 components of enoxaparin and 20 components of nadroparin were separated and unambiguously characterized with mass spectrum, including eight common disaccharides, and the special structural domains resistant to enzyme digestion which have the 3-O sulfated residue and/or characteristic terminal residues and the linkage region tetrasaccharides.
pharmacology & pharmacy,chemistry, analytical
What problem does this paper attempt to address?